Induced somatic inactivation of STAT3 in mice triggers the development of a fulminant form of enterocolitis

Cytokine

Volumn 26, Issue 2, 2004, Pages 45-56

  Alonzi, Tonino ^a,b,f   Newton, Ian P ^b   Bryce, Paul J ^b,g   Di Carlo, Emma ^c   Lattanzio, Giuseppe ^c   Tripodi, Marco ^a,d   Musiani, Piero ^c   Poli, Valeria ^b,e  

^a NATIONAL INSTITUTE FOR INFECTIOUS DISEASES L SPALLANZANI   (Italy)

^b UNIVERSITY OF DUNDEE   (United Kingdom)

^c UNIVERSITY OF CHIETI   (Italy)

^d SAPIENZA UNIVERSITY OF ROME   (Italy)

^e UNIVERSITY OF TURIN   (Italy)

^f Padiglione del Vecchio   (Italy)

^g BOSTON CHILDREN S HOSPITAL   (United States)

Author keywords

Conditional gene inactivation; Enterocolitis; Inflammation; Inflammatory bowel disease; STAT3

Indexed keywords

ANTIBIOTIC AGENT; CD4 ANTIGEN; CELL ADHESION MOLECULE; INTERFERON; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 6; NEUTRALIZING ANTIBODY; PROTEIN P40; STAT3 PROTEIN;

ADIPOSE TISSUE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL FUNCTION; CELL TYPE; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DISEASE COURSE; ENTEROCOLITIS; EPITHELIUM CELL; GENE INACTIVATION; GENE MUTATION; GENETIC CODE; GRANULOCYTE; HOMEOSTASIS; INDUCED MUTATION; INTESTINE EPITHELIUM; INTESTINE MUCOSA; LARGE INTESTINE; LIVER; MACROPHAGE; NONHUMAN; PRIORITY JOURNAL; WASTING SYNDROME;

ANIMALS; ANTI-BACTERIAL AGENTS; ANTIBODIES; COLON; CYTOKINES; DNA-BINDING PROTEINS; ENTEROCOLITIS; GENE DELETION; INTERLEUKIN-12; MICE; MONOCYTES; NEUTROPHILS; PHOSPHORYLATION; STAT3 TRANSCRIPTION FACTOR; TRANS-ACTIVATORS; WASTING SYNDROME;

EID: 1642619154     PISSN: 10434666     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cyto.2003.12.002     Document Type: Article

References (42)

1. Barkin R., Lewis J.H. Overview of inflammatory bowel disease in humans. Semin Vet Med Surg (Small Anim). 7:1992;117-127.
2. Sadlack B., Merz H., Schorle H., Schimpl A., Feller A.C., Horak I. Ulcerative colitis-like disease in mice with a disrupted interleukin-2 gene. Cell. 75:1993;253-261.
3. Willerford D.M., Chen J., Ferry J.A., Davidson L., Ma A., Alt F.W. Interleukin-2 receptor alpha chain regulates the size and content of the peripheral lymphoid compartment. Immunity. 3:1995;521-530.
4. Kuhn R., Lohler J., Rennick D., Rajewsky K., Muller W. Interleukin-10-deficient mice develop chronic enterocolitis. Cell. 75:1993;263-274.
5. Kulkarni A.B., Ward J.M., Yaswen L., Mackall C.L., Bauer S.R., Huh C.G., et al. Transforming growth factor-beta 1 null mice. An animal model for inflammatory disorders. Am J Pathol. 146:1995;264-275.
6. Mombaerts P., Mizoguchi E., Grusby M.J., Glimcher L.H., Bhan A.K., Tonegawa S. Spontaneous development of inflammatory bowel disease in T cell receptor mutant mice. Cell. 75:1993;274-282.
7. Powrie F., Leach M.W., Mauze S., Caddle L.B., Coffman R.L. Phenotypically distinct subsets of CD4+ T cells induce or protect from chronic intestinal inflammation in C. B-17 scid mice. Int Immunol. 5:1993;1461-1471.
8. Hermiston M.L., Gordon J.I. Inflammatory bowel disease and adenomas in mice expressing a dominant negative N-cadherin. Science. 270:1995;1203-1207.
9. Panwala C.M., Jones J.C., Viney J.L. A novel model of inflammatory bowel disease: mice deficient for the multiple drug resistance gene, mdr1a, spontaneously develop colitis. J Immunol. 161:1998;5733-5744.
10. Bromberg J., Darnell J.E. The role of STATs in transcriptional control and their impact on cellular function. Oncogene. 19:2000;2468-2473.
11. Akira S. Roles of STAT3 defined by tissue-specific gene targeting. Oncogene. 19:2000;2607-2611.
12. Takeda K., Noguchi K., Shi W., Tanaka T., Matsumoto M., Yoshida N., et al. Targeted disruption of the mouse Stat3 gene leads to early embryonic lethality. Proc Natl Acad Sci U S A. 94:1997;3801-3804.
13. Alonzi T., Maritano D., Gorgoni B., Rizzuto G., Libert C., Poli V. Essential role of STAT3 in the control of the acute-phase response as revealed by inducible gene inactivation in the liver. Mol Cell Biol. 21:2001;1621-1632.
14. Kuhn R., Schwenk F., Aguet M., Rajewsky K. Inducible gene targeting in mice. Science. 269:1995;1427-1429.
15. Betz U.A., Bloch W., van den Broek M., Yoshida K., Taga T., Kishimoto T., et al. Postnatally induced inactivation of gp130 in mice results in neurological, cardiac, hematopoietic, immunological, hepatic, and pulmonary defects. J Exp Med. 188:1998;1955-1965.
16. Vooijs M., Jonkers J., Berns A. A highly efficient ligand-regulated Cre recombinase mouse line shows that LoxP recombination is position dependent. EMBO Rep. 2:2001;292-297.
17. Parronchi P., Romagnani P., Annunziato F., Sampognaro S., Becchio A., Giannarini L., et al. Type 1 T-helper cell predominance and interleukin-12 expression in the gut of patients with Crohn's disease. Am J Pathol. 150:1997;823-832.
18. Ehrhardt R.O., Ludviksson B.R., Gray B., Neurath M., Strober W. Induction and prevention of colonic inflammation in IL-2-deficient mice. J Immunol. 158:1997;566-573.
19. Davidson N.J., Hudak S.A., Lesley R.E., Menon S., Leach M.W., Rennick D.M. IL-12, but not IFN-gamma, plays a major role in sustaining the chronic phase of colitis in IL-10-deficient mice. J Immunol. 161:1998;3143-3149.
20. Garside P., Felstein M.V., Green E.A., Mowat A.M. The role of interferon alpha/beta in the induction of intestinal pathology in mice. Immunology. 74:1991;279-283.
21. Takeda K., Clausen B.E., Kaisho T., Tsujimura T., Terada N., Forster I., et al. Enhanced Th1 activity and development of chronic enterocolitis in mice devoid of Stat3 in macrophages and neutrophils. Immunity. 10:1999;39-49.
22. Welte T., Zhang S.S., Wang T., Zhang Z., Hesslein D.G., Yin Z., et al. STAT3 deletion during hematopoiesis causes Crohn's disease-like pathogenesis and lethality: a critical role of STAT3 in innate immunity. Proc Natl Acad Sci U S A. 100:2003;1879-1884.
23. Riley J.K., Takeda K., Akira S., Schreiber R.D. Interleukin-10 receptor signaling through the JAK-STAT pathway. Requirement for two distinct receptor-derived signals for anti-inflammatory action. J Biol Chem. 274:1999;16513-16521.
24. Du X., Williams D.A. Interleukin-11: review of molecular, cell biology, and clinical use. Blood. 89:1997;3897-3908.
25. Ernst M., Inglese M., Waring P., Campbell I.K., Bao S., Clay F.J., et al. Defective gp130-mediated signal transducer and activator of transcription (STAT) signaling results in degenerative joint disease, gastrointestinal ulceration, and failure of uterine implantation. J Exp Med. 194:2001;189-203.
26. Tebbutt N.C., Giraud A.S., Inglese M., Jenkins B., Waring P., Clay F.J., et al. Reciprocal regulation of gastrointestinal homeostasis by SHP2 and STAT-mediated trefoil gene activation in gp130 mutant mice. Nat Med. 8:2002;1089-1097.
27. Atreya R., Mudter J., Finotto S., Mullberg J., Jostock T., Wirtz S., et al. Blockade of interleukin 6 trans signaling suppresses T-cell resistance against apoptosis in chronic intestinal inflammation: evidence in Crohn disease and experimental colitis in vivo. Nat Med. 6:2000;583-588.
28. Binion D.G., West G.A., Volk E.E., Drazba J.A., Ziats N.P., Petras R.E., et al. Acquired increase in leucocyte binding by intestinal microvascular endothelium in inflammatory bowel disease. Lancet. 352:1998;1742-1746.
29. Shimizu Y., Newman W., Tanaka Y., Shaw S. Lymphocyte interactions with endothelial cells. Immunol Today. 13:1992;106-112.
30. Tesch G.H., Maifert S., Schwarting A., Rollins B.J., Kelley V.R. Monocyte chemoattractant protein 1-dependent leukocytic infiltrates are responsible for autoimmune disease in MRL-Fas(lpr) mice. J Exp Med. 190:1999;1813-1824.
31. Kobayashi M., Kweon M.N., Kuwata H., Schreiber R.D., Kiyono H., Takeda K., et al. Toll-like receptor-dependent production of IL-12p40 causes chronic enterocolitis in myeloid cell-specific Stat3-deficient mice. J Clin Invest. 111:2003;1297-1308.
32. Cavallo F., Di Carlo E., Butera M., Verrua R., Colombo M.P., Musiani P., et al. Immune events associated with the cure of established tumors and spontaneous metastases by local and systemic interleukin 12. Cancer Res. 59:1999;414-421.
33. Westlin W.F., Gimbrone M.A. Neutrophil-mediated damage to human vascular endothelium. Role of cytokine activation. Am J Pathol. 142:1993;117-128.
34. McLemore M.L., Grewal S., Liu F., Archambault A., Poursine-Laurent J., Haug J., et al. STAT-3 activation is required for normal G-CSF-dependent proliferation and granulocytic differentiation. Immunity. 14:2001;193-204.
35. Sartor R.B. Role of intestinal microflora in initiation and perpetuation of inflammatory bowel disease. Can J Gastroenterol. 4:1990;271-277.
36. Wysocka M., Kubin M., Vieira L.Q., Ozmen L., Garotta G., Scott P., et al. Interleukin-12 is required for interferon-gamma production and lethality in lipopolysaccharide-induced shock in mice. Eur J Immunol. 25:1995;672-676.
37. Qin S., Cobbold S., Tighe H., Benjamin R., Waldmann H. CD4 monoclonal antibody pairs for immunosuppression and tolerance induction. Eur J Immunol. 17:1987;1159-1165.
38. van der Waaij D., Sturm C.A. Antibiotic decontamination of the digestive tract of mice. Technical procedures. Lab Anim Care. 18:1968;1-10.
39. Doyle A.G., Fraser I.P. Murine macrophages: isolation, cultivation and characterization. Herzenberg L.A., Weir D.M., Herzenberg L.A. Weir's handbook of experimental immunology. 1996;154.1-154.8 Blackwell C. Blackwell Science, Boston.
40. Berg D.J., Davidson N., Kuhn R., Muller W., Menon S., Holland G., et al. Enterocolitis and colon cancer in interleukin-10-deficient mice are associated with aberrant cytokine production and CD4(+) TH1-like responses. J Clin Invest. 98:1996;1010-1020.
41. Rovero S., Amici A., Carlo E.D., Bei R., Nanni P., Quaglino E., et al. DNA vaccination against rat her-2/Neu p185 more effectively inhibits carcinogenesis than transplantable carcinomas in transgenic BALB/c mice. J Immunol. 165:2000;5133-5142.
42. Di Carlo E., Comes A., Basso S., De Ambrosis A., Meazza R., Musiani P., et al. The combined action of IL-15 and IL-12 gene transfer can induce tumor cell rejection without T and NK cell involvement. J Immunol. 165:2000;3111-3118.